Previously, apatinib showed useful effects when applied in combination with other drugs such as apatinib combination with CQ-induced apoptosis in ESCC cells through activating IRE-1α-AKT-mTOR signaling pathway [30]. Here, AKT1 is linked to esophageal squamous cell carcinoma.